Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits.

Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Abstract Text:

    mark p mooneyMark P Mooney,h wolfgang loskenH Wolfgang Losken,amr m moursiAmr M Moursi,james bradleyJames Bradley,kodi azariKodi Azari,t oguz acarturkT Oguz Acarturk,gregory m cooperGregory M Cooper,brian thompsonBrian Thompson,lynne a oppermanLynne A Opperman,michael i siegelMichael I Siegel,

    BACKGROUND: Postoperative resynostosis is a common clinical finding. It has been suggested that an overexpression of transforming growth factor (TGF)-beta2 may be related to craniosynostosis and may contribute to postoperative resynostosis. Interference with TGF-beta2 function with the use of neutralizing antibodies may inhibit resynostosis. The present study was designed to test this hypothesis. METHODS: New Zealand White rabbits with bilateral coronal suture synostosis were used as suturectomy controls (group 1, n = 9) or given suturectomy with nonspecific, control immunoglobulin G antibody (group 2, n = 9) or suturectomy with anti-TGF-beta2 antibody (group 3, n = 11). At 10 days of age, a 3 x 15-mm coronal suturectomy was performed. The sites in groups 2 and 3 were immediately filled with 0.1 cc of a slowly resorbing collagen gel mixed with either immunoglobulin G (100 mug per suture) or anti-TGF-beta2 (100 mug per suture). Three-dimensional computed tomography scan reconstructions of the defects were obtained at 10, 25, 42, and 84 days of age, and the sutures were harvested for histomorphometric analysis. RESULTS: Computed tomography scan data revealed that the suturectomy sites treated with anti-TGF-beta2 showed significantly (p < 0.05) greater areas through 84 days of age compared with controls. Histomorphometry also showed that suturectomy sites treated with anti-TGF-beta2 had patent suturectomy sites and more fibrous tissue in the defects compared with sites in control rabbits and had significantly (p < 0.001) less new bone area (by approximately 215 percent) in the suturectomy site. CONCLUSIONS: These data support the initial hypothesis that interference with TGF-beta2 function inhibited postoperative resynostosis in this rabbit model. They also suggest that this biologically based therapy may be a potential surgical adjunct to retard postoperative resynostosis in infants with craniosynostosis.

    Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Publishing Authors By Initials

    mp mooneyMP Mooney,hw loskenHW Losken,am moursiAM Moursi,j bradleyJ Bradley,k azariK Azari,to acarturkTO Acarturk,gm cooperGM Cooper,b thompsonB Thompson,la oppermanLA Opperman,mi siegelMI Siegel,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta: transforming growth factor beta2 research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta: transforming growth factor beta2 research

    PUBMED ID PMID:

    MEDLINE DATE:

    Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Plastic and reconstructive surgery

    VOLUME: 119

    Page Numbers: 1200-12; discussion 1213-5

    Journal Abbreviation: Plast. Reconstr. Surg.

    ISSN: 1529-4242

    DAY: 1

    MONTH: Apr

    YEAR: 2007

    Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1306050

    Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta2

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Information

    Substance Name: Transforming Growth Factor beta2

    Registry Number: 0

    Grant and Affiliation Information for Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits.

    AFFILIATION: Department of Oral Medicine and Pathology, the Cleft Palate-Craniofacial Center, and the School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. mpm4@pitt.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDCR

    GRANT: DE13078

    ACRONYM: DE

    MEDLINETA: Plast Reconstr Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News